Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. This gene is widely expressed in human tissues and has increased expression in actively dividing cells, such as those in testis, thymus, fetal liver, and carcinomas. Its protein localizes to the nucleus and has been shown to promote the stability and nuclear accumulation of a transcriptionally active p53 molecule and, in vitro, to phosphorylate Thr18 of p53 and reduce p53 ubiquitination. This gene, therefore, may regulate cell proliferation. This protein also phosphorylates histone, casein, and the transcription factors ATF2 (activating transcription factor 2) and c-JUN. [provided by RefSeq, Jul 2008]
VRK1 (VRK Serine/Threonine Kinase 1) is a Protein Coding gene. Diseases associated with VRK1 include Pontocerebellar Hypoplasia, Type 1A and Pontocerebellar Hypoplasia Type 1. Among its related pathways are Initiation of Nuclear Envelope Reformation and Mitotic Metaphase and Anaphase. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein serine/threonine kinase activity. An important paralog of this gene is VRK2.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH14J096796 | Promoter/Enhancer | 2 | EPDnew Ensembl ENCODE CraniofacialAtlas | 258.3 | +0.6 | 597 | 3.4 | CHD2 TBP SP1 SIX5 NR2C1 MNT IKZF1 SMAD5 ETS1 IRF2 | VRK1 ATG2B HSALNG0103531 | |
GH14J096741 | Promoter | 1.6 | EPDnew Ensembl CraniofacialAtlas | 250.2 | -55.8 | -55803 | 1 | ZBTB10 CTCF ZIC2 ZNF610 SIN3A REST TRIM22 SMC3 GABPB1 RAD21 | LINC02299 VRK1 piR-59962 lnc-ATG2B-18 ENSG00000287772 PAPOLA | |
GH14J096888 | Enhancer | 1.2 | UCNEbase Ensembl | 11.2 | +91.5 | 91497 | 2 | FEZF1 ZIC2 ZNF513 KLF7 ZNF341 ZNF843 ZNF146 BCL11B PRDM6 CBFB | PAPOLA VRK1 ATG2B HSALNG0103532 piR-31199-111 | |
GH14J096824 | Enhancer | 0.6 | Ensembl ENCODE | 19.7 | +28.6 | 28592 | 3.4 | ZIC2 ZBTB33 EGR2 ZFHX2 PRDM1 | VRK1 HSALNG0103531 | |
GH14J096821 | Enhancer | 0.4 | Ensembl ENCODE | 18.9 | +24.3 | 24334 | 0.9 | PRDM10 | VRK1 HSALNG0103531 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000166 | nucleotide binding | IEA | -- |
GO:0004672 | protein kinase activity | IEA,IDA | 22194607 |
GO:0004674 | protein serine/threonine kinase activity | IDA | 21543316 |
GO:0005515 | protein binding | IPI | 15105425 |
GO:0005524 | ATP binding | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005634 | nucleus | IDA | 22194607 |
GO:0005654 | nucleoplasm | TAS | -- |
GO:0005730 | nucleolus | IDA | -- |
GO:0005737 | cytoplasm | IBA | 21873635 |
GO:0005795 | Golgi stack | IDA | 19103756 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Cell Cycle, Mitotic |
.83
|
.60
|
2 | Initiation of Nuclear Envelope Reformation | ||
3 | Mitotic Metaphase and Anaphase |
.94
|
|
4 | DNA Damage | ||
5 | Mitotic Prophase |
.57
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006468 | protein phosphorylation | IEA,IDA | 22194607 |
GO:0007049 | cell cycle | IEA | -- |
GO:0007077 | mitotic nuclear envelope disassembly | TAS | -- |
GO:0007084 | mitotic nuclear envelope reassembly | TAS | -- |
GO:0016310 | phosphorylation | IEA | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
ATP | Investigational | Nutra | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
ADP |
|
58-64-0 |
|
ExUns: | 1a | · | 1b | ^ | 2 | ^ | 3 | ^ | 4 | ^ | 5 | ^ | 6a | · | 6b | ^ | 7 | ^ | 8 | ^ | 9 | ^ | 10 | ^ | 11 | ^ | 12 | ^ | 13 | ^ | 14 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | |||||||||||||||||||||||||||||
SP2: | |||||||||||||||||||||||||||||||
SP3: | - | ||||||||||||||||||||||||||||||
SP4: |
This gene was present in the common ancestor of animals.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | VRK1 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | VRK1 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | VRK1 30 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Vrk1 30 |
|
||
Mouse (Mus musculus) |
Mammalia | Vrk1 30 17 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | VRK1 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | VRK1 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | VRK1 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | VRK1 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | vrk1 30 |
|
||
MGC75762 30 |
|
||||
African clawed frog (Xenopus laevis) |
Amphibia | vrk1-prov 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | vrk1 30 31 |
|
OneToOne | |
wufe16f06 30 |
|
||||
Rainbow Trout (Oncorhynchus mykiss) |
Actinopterygii | Omy.4919 30 |
|
||
African malaria mosquito (Anopheles gambiae) |
Insecta | AgaP_AGAP001933 30 |
|
||
Fruit Fly (Drosophila melanogaster) |
Insecta | BcDNA:LD09009 32 |
|
|
|
ball 31 |
|
ManyToMany | |||
CG8878 31 |
|
ManyToMany | |||
Worm (Caenorhabditis elegans) |
Secernentea | vrk-1 30 31 |
|
OneToMany | |
F28B12.3 32 |
|
|
|||
Sea Squirt (Ciona savignyi) |
Ascidiacea | CSA.6830 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 14 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
834310 | Uncertain Significance: Pontocerebellar hypoplasia type 1 | 96,852,939(+) |
T/A NM_003384.3(VRK1):c.483T>A (p.Ile161=) |
SYNONYMOUS | |
837802 | Uncertain Significance: Pontocerebellar hypoplasia type 1 | 96,860,671(+) |
A/T NM_003384.3(VRK1):c.1004A>T (p.Asp335Val) |
MISSENSE | |
837803 | Uncertain Significance: Pontocerebellar hypoplasia type 1 | 96,853,141(+) |
T/A NM_003384.3(VRK1):c.551T>A (p.Leu184His) |
MISSENSE | |
839347 | Uncertain Significance: Pontocerebellar hypoplasia type 1 | 96,852,895(+) |
A/G NM_003384.3(VRK1):c.439A>G (p.Lys147Glu) |
MISSENSE | |
842535 | Likely Pathogenic: Pontocerebellar hypoplasia type 1 | 96,852,852(+) |
TCGCTTTGGGAGTGAC
NM_003384.3(VRK1):c.402_890-895del |
SPLICE_ACCEPTOR_VARIANT,SPLICE_DONOR |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv1964n100 | CNV | gain | 25217958 |
esv3303068 | CNV | tandem duplication | 20981092 |
esv3581399 | CNV | loss | 25503493 |
esv3635428 | CNV | loss | 21293372 |
nsv1043916 | CNV | gain | 25217958 |
nsv1051182 | CNV | loss | 25217958 |
nsv510650 | CNV | deletion | 20534489 |
Disorder | Aliases | PubMed IDs |
---|---|---|
pontocerebellar hypoplasia, type 1a |
|
|
pontocerebellar hypoplasia type 1 |
|
|
microcephaly-complex motor and sensory axonal neuropathy syndrome |
|
|
spinal muscular atrophy |
|
|
autosomal recessive non-syndromic intellectual disability |
|